Qiagen NV (WBO:QGE2)
€ 43.02 0.09 (0.21%) Market Cap: 9.55 Bil Enterprise Value: 9.97 Bil PE Ratio: 110.35 PB Ratio: 2.83 GF Score: 85/100

Qiagen NV at Bank of America Global Research Healthcare Conference (Virtual) Transcript

May 12, 2021 / 12:00PM GMT
Release Date Price: €39.62 (+0.10%)
Derik De Bruin
BofA Securities, Research Division - MD of Equity Research

Great. Good morning, everyone. Welcome to the second day of Bank of America's 2021 Virtual [Viva] Las Vegas Health Care Conference. We've got a long line today, lots of companies presenting. To kick off this morning's session, I'm here with my colleague, Mike Ryskin. And our first company to present this morning is QIAGEN. With us from QIAGEN, we have CFO, Roland Sackers; Vice President, Head of Corporate Communications and IR, John Gilardi; and Phoebe Loh, Senior Director of IR. Roland, John, Phoebe, welcome. Thanks for being here today. Appreciate it.

So with that, to set the stage, any opening comments or I can jump right into the Q&A. I got a whole bunch.

Roland Sackers
QIAGEN N.V. - CFO, MD & Member of Management Board

No. I will have just very few remarks from my side. And first of all, Derik, thanks for having us. Very much looking forward to the next year, hopefully, again in Vegas.

As you all might have seen, we clearly had quite a strong start into

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot